71,604 Amrize Ltd $AMRZ Shares Sold by Generali Asset Management SPA SGR

Key Points

• Generali Asset Management sharply reduced its Amrize stake by selling 71,604 shares, leaving it with 6,026 shares valued at approximately $225,000.
• Amrize reported quarterly revenue of $3.77 billion and EPS of $1.05, matching consensus, while revenue increased 2.6% year over year. The company also declared a quarterly dividend of $0.11 per share.
• Insider buying totaled 48,983 shares worth about $2.16 million over the past 90 days, but analyst sentiment remains mixed, with Amrize carrying an overall “Hold” rating and an average price target of $49.24.

Generali Asset Management SPA SGR lessened its stake in Amrize Ltd (NYSE:AMRZ - Free Report) by 92.2% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 6,026 shares of the company's stock after selling 71,604 shares during the quarter. Generali Asset Management SPA SGR's holdings in Amrize were worth $225,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in AMRZ. Asset Management One Co. Ltd. boosted its stake in shares of Amrize by 1.7% during the 3rd quarter. Asset Management One Co. Ltd. now owns 188,171 shares of the company's stock valued at $7,036,000 after buying an additional 3,173 shares during the period. Brookstone Capital Management acquired a new position in shares of Amrize in the third quarter worth $208,000. Revisor Wealth Management LLC increased its stake in shares of Amrize by 25.0% in the third quarter. Revisor Wealth Management LLC now owns 7,785 shares of the company's stock worth $293,000 after acquiring an additional 1,557 shares during the last quarter. IFP Advisors Inc raised its holdings in shares of Amrize by 1,707.3% during the third quarter. IFP Advisors Inc now owns 1,988 shares of the company's stock worth $74,000 after acquiring an additional 1,878 shares in the last quarter. Finally, Peddock Capital Advisors LLC raised its holdings in shares of Amrize by 3.9% during the third quarter. Peddock Capital Advisors LLC now owns 21,017 shares of the company's stock worth $786,000 after acquiring an additional 790 shares in the last quarter.

Insider Activity at Amrize

In related news, insider Jaime Hill purchased 1,500 shares of the firm's stock in a transaction dated Tuesday, August 11th. The stock was bought at an average price of $47.12 per share, for a total transaction of $70,680.00. Following the purchase, the insider owned 29,698 shares in the company, valued at $1,399,369.76. The trade was a 5.32% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Baris Oran acquired 3,000 shares of the stock in a transaction dated Tuesday, August 11th. The shares were bought at an average cost of $47.38 per share, for a total transaction of $142,140.00. Following the acquisition, the chief financial officer owned 3,000 shares in the company, valued at $142,140. The trade was a ∞ increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have purchased a total of 48,983 shares of company stock worth $2,158,755 in the last 90 days. Insiders own 0.54% of the company's stock.

Amrize Stock Down 0.5%

AMRZ stock opened at $41.40 on Friday. The firm has a market cap of $22.90 billion, a PE ratio of 18.73, a PEG ratio of 1.49 and a beta of 0.20. Amrize Ltd has a 1 year low of $35.78 and a 1 year high of $65.94. The company has a fifty day simple moving average of $39.73 and a 200 day simple moving average of $50.59. The company has a current ratio of 1.10, a quick ratio of 0.73 and a debt-to-equity ratio of 0.33.

Amrize (NYSE:AMRZ - Get Free Report) last posted its earnings results on Wednesday, October 28th. The company reported $1.05 EPS for the quarter, hitting the consensus estimate of $1.05. Amrize had a net margin of 9.93% and a return on equity of 9.96%. The firm had revenue of $3.77 billion for the quarter. During the same period in the previous year, the company earned $0.98 earnings per share. The company's quarterly revenue was up 2.6% compared to the same quarter last year. Sell-side analysts anticipate that Amrize Ltd will post 2.41 EPS for the current fiscal year.

Amrize Announces Dividend

The business also recently declared a dividend, which will be paid on Wednesday, November 18th. Stockholders of record on Tuesday, November 10th will be paid a dividend of $0.11 per share. The ex-dividend date is Tuesday, November 10th. Amrize's dividend payout ratio is 4.98%.

More Amrize News

Here are the key news stories impacting Amrize this week:

• Positive Sentiment: Third-quarter earnings exceeded some estimates. Amrize reported quarterly adjusted earnings of approximately $1.02 per share, above the $0.98 consensus estimate, while net income rose 3.3% year over year to $558 million. Revenue increased roughly 2.2%-2.6% to $3.77 billion. Amrize Q3 Earnings Surpass Estimates
• Positive Sentiment: Pricing remained a key strength. Aggregates pricing increased 6.9% and cement pricing rose 1.8%, helping offset inflationary pressures and support profitability. Amrize: 3 Key Takeaways for Long-Term Investors
• Positive Sentiment: Shareholder returns received support. Amrize completed its $1 billion share-repurchase program and plans to cancel the repurchased shares, which could reduce the share count. It also declared a quarterly dividend of $0.11 per share, payable November 18 to eligible shareholders. Amrize Completes $1 Billion Share Repurchase Program
• Neutral Sentiment: Results were broadly resilient but not uniformly strong. EPS matched the company’s reported consensus estimate of $1.05 in one earnings report, while adjusted earnings were described as flat year over year, highlighting limited underlying earnings growth.
• Negative Sentiment: Full-year revenue guidance was reduced relative to expectations. Amrize now expects 2026 revenue of $12.2 billion-$12.4 billion, below the roughly $12.5 billion analyst consensus, signaling softer demand or greater operating pressure than anticipated.
• Negative Sentiment: Wells Fargo cut its price target from $40 to $39 and maintained an “equal weight” rating. The revision indicates limited near-term upside in the bank’s view and adds to the cautious outlook surrounding AMRZ.

Wall Street Analysts Forecast Growth

AMRZ has been the topic of a number of recent research reports. Sanford C. Bernstein restated an "outperform" rating and issued a $60.00 target price on shares of Amrize in a research note on Monday, September 21st. Truist Financial cut their price target on Amrize from $48.00 to $35.00 and set a "hold" rating for the company in a research note on Monday, October 5th. Deutsche Bank Aktiengesellschaft reduced their price target on Amrize from $64.00 to $56.00 and set a "buy" rating for the company in a report on Wednesday, September 23rd. Bank of America cut Amrize from a "neutral" rating to an "underperform" rating and lowered their price target for the company from $50.00 to $40.00 in a research note on Wednesday, September 2nd. Finally, Zacks Research downgraded Amrize from a "hold" rating to a "strong sell" rating in a report on Wednesday, August 19th. Eight equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have issued a Sell rating to the company's stock. According to MarketBeat, Amrize has an average rating of "Hold" and an average target price of $49.24.

Amrize Company Profile

Amrize is a North American building-solutions company that supplies materials and products used in residential, commercial and infrastructure construction. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, roofing systems and other building products.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and related operations. Its products support applications ranging from roads, bridges and other public infrastructure to commercial buildings and residential construction.

Amrize was formed through the separation of Holcim's North American business and began trading independently on the New York Stock Exchange under the symbol AMRZ in 2025.

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.